Research / DE / Fundamental state Inspectable configuration
State dimensions Filing 0001558370-21-007781 General Corporate
Capex intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.38% · OPTIONAL · VALID
Operating cash generation 71th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.63% · OPTIONAL · VALID
Share-count growth 56th Own-history percentile · N=16
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.29% · CORE · VALID
Revenue growth 95th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
30.31% · CORE · VALID
Inventory pressure 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
50.11% · OPTIONAL · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
20.23% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.13% · OPTIONAL · VALID
SBC intensity 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.25% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 44 states Self-history eligible
Aug 1, 2021 8/8 normalized Level 3 Oct 31, 2021 7/7 normalized Level 3 Jan 30, 2022 8/8 normalized Level 3 May 1, 2022 8/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 30, 2022 7/7 normalized Level 3 Jan 29, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Oct 29, 2023 7/7 normalized Level 3 Jan 28, 2024 7/7 normalized Level 3 Apr 28, 2024 7/7 normalized Level 3 Jul 28, 2024 7/7 normalized Level 3 Oct 27, 2024 7/7 normalized Level 3 Jan 26, 2025 7/7 normalized Level 3 Apr 27, 2025 7/7 normalized Level 3 Jul 27, 2025 7/7 normalized Level 3 Feb 1, 2026 7/7 normalized Level 3 May 3, 2026 7/7 normalized Level 3 Aug 2, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 1.69%
Current 1.38%
Delta -0.31% Cash Generation Increased
Previous 1.57%
Current 13.63%
Delta 12.06% Dilution Decreased
Previous -0.06%
Current -0.29%
Delta -0.24% Growth Increased
Previous 19.41%
Current 30.31%
Delta 10.91% Inventory Pressure Decreased
Previous 65.36%
Current 50.11%
Delta -15.26% Profitability Increased
Previous 17.98%
Current 20.23%
Delta 2.25% R And D Intensity Decreased
Previous 4.02%
Current 3.13%
Delta -0.89% Sbc Intensity Increased
Previous 0.16%
Current 0.25%
Delta 0.08% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.